00:00 Speaker A
All proper, properly, headline simply coming throughout in the previous few minutes. Bloomberg reporting the Trump administration will drop the Biden period Medicare weight problems drug protection proposal. In late November, the Biden administration proposed a rule that might have made thousands and thousands of Individuals with weight problems eligible to have common weight reduction medication like Wegovy or Zepbound coated by Medicare or Medicaid. Now, in keeping with Bloomberg, the Facilities for Medicare and Medicaid Companies may rethink protection of the medication sooner or later, however HHS Secretary Robert Kennedy Jr. is an opponent of weight reduction medication, and shares of each Eli Lilly and Novo Nordisk are beneath stress in after-hours buying and selling. Not precisely the headlines these corporations needed to see after the week that we have seen within the markets total.
Source link